光庫科技(300620.SZ):公司開發的新一代薄膜鈮酸鋰光子集成技術,既可以用在相干傳輸形式,也可以用於非相干傳輸模式
格隆匯5月25日丨光庫科技(300620.SZ)在5月23日下午接受特定對象調研表示,鈮酸鋰調製器芯片及器件主要用於100Gbps以上的長距骨幹網相干通訊和單波100/200Gbps的超高速數據中心中,公司開發的新一代薄膜鈮酸鋰光子集成技術,既可以用在相干傳輸形式,也可以用於非相干傳輸模式。此外,薄膜鈮酸鋰調製器在光子集成電路中扮演關鍵角色,用於光學信號的調製、分路和切換等功能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.